Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 6Prostatic Neoplasms 6Vaginal Neoplasms 2Breast Neoplasms 2Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Locally Advanced Cervical Adenocarcinoma 1Gynecologic Cancer 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinosarcoma 1Carcinoma, Hepatocellular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1

Interventions

Brachytherapy 2trastuzumab deruxtecan 1liposomal doxorubicin 1entinostat 1dostarlimab 1bintrafusp alfa protein, human 1Therapeutic Touch 1Surveys and Questionnaires 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Doxorubicin 1Dehydroepiandrosterone 1Congresses as Topic 1Cisplatin 1Bupropion 1Bevacizumab 1Axitinib 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vaginal Neoplasms × Brachytherapy × 90 days × Clear all
NCT02466971 2026-05-29

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT03634267 2026-04-15

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
26 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡